As discovered by our research group, in the acute hepatitis mouse model induced by CCl4, both liver inflammatory damage and hepatocyte apoptosis were significantly mitigated for ASPP2 heterozygous deletion (ASPP2+/−) mice. Here, TP53BP2 is linked to Acute hepatitis.